Fund profile

Nina Capital

Spain

Leading

About

Nina Capital is a specialized venture capital firm based in Barcelona, focusing on early-stage investments in health technology. Founded by Marta Gaia Zanchi, the firm invests across Europe, the United States, Canada, Israel, and Australia. Nina Capital leverages the Biodesign process from Stanford, which emphasizes a need-driven and value-based approach to healthcare innovation. Their investment strategy spans pre-seed to seed stages, with typical investment sizes ranging from €200k to €1.5m​. The firm supports startups that apply advanced data science, engineering innovation, and IT-enabled products to solve healthcare challenges. Notable portfolio companies include QuantHealth, which uses AI to predict patient responses in clinical trials, and Cardiomatics, offering automated ECG interpretation to improve healthcare efficiency​. The core team, led by principals like Anastassiou and Yahel Halamish, combines deep expertise in healthcare, technology, and investment. They are committed to diversity and multidisciplinary collaboration, fostering an inclusive environment that promotes innovative solutions to complex healthcare problems.

Details

Highlights

$494.8k

Historical average check

$15M

Historical max check

October 2024

Last investment date

68

Investments

Healthtech & Wellness

Software & Apps

Pharma

Biotech

Legal & Professional services

AI & Deep Tech

Lifestyle

Social media

Other

Funds that also invest in AI & Deep Tech